Fidelity Investments’s Ambrx Biopharma, Inc. Common Stock AMAM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-1,474,258
| Closed | -$21M | – | 5817 |
|
|
2023
Q4 | $21M | Sell |
1,474,258
-286,800
| -16% | -$4.08M | ﹤0.01% | 1608 |
|
|
2023
Q3 | $20.3M | Sell |
1,761,058
-449,560
| -20% | -$5.17M | ﹤0.01% | 1579 |
|
|
2023
Q2 | $36.4M | Hold |
2,210,618
| – | – | ﹤0.01% | 1389 |
|
|
2023
Q1 | $19.7M | Sell |
2,210,618
-485,446
| -18% | -$4.33M | ﹤0.01% | 1613 |
|
|
2022
Q4 | $6.12M | Sell |
2,696,064
-892,403
| -25% | -$2.03M | ﹤0.01% | 2057 |
|
|
2022
Q3 | $3.88M | Sell |
3,588,467
-269,212
| -7% | -$291K | ﹤0.01% | 2241 |
|
|
2022
Q2 | $10.2M | Buy |
3,857,679
+32,320
| +0.8% | +$85.6K | ﹤0.01% | 1956 |
|
|
2022
Q1 | $15.8M | Sell |
3,825,359
-29,666
| -0.8% | -$122K | ﹤0.01% | 1901 |
|
|
2021
Q4 | $34.8M | Sell |
3,855,025
-1,200
| -0% | -$10.8K | ﹤0.01% | 1571 |
|
|
2021
Q3 | $50.3M | Buy |
3,856,225
+89,285
| +2% | +$1.16M | ﹤0.01% | 1407 |
|
|
2021
Q2 | $68.7M | Buy |
+3,766,940
| New | +$68.7M | 0.01% | 1293 |
|